These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

927 related items for PubMed ID: 12544288

  • 1. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD.
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [Abstract] [Full Text] [Related]

  • 2. [Hypercalciuria].
    Wróblewski T, Wystrychowski A.
    Przegl Lek; 2011 Feb; 68(2):107-13. PubMed ID: 21751520
    [Abstract] [Full Text] [Related]

  • 3. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY, Sakhaee K, Fuller CJ.
    Trans Assoc Am Physicians; 1983 Feb; 96():294-305. PubMed ID: 6679957
    [Abstract] [Full Text] [Related]

  • 4. Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis.
    Pak CY, Peterson RD, Poindexter J.
    J Urol; 2002 Jul; 168(1):31-4. PubMed ID: 12050486
    [Abstract] [Full Text] [Related]

  • 5. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL.
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [Abstract] [Full Text] [Related]

  • 6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group.
    Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027
    [Abstract] [Full Text] [Related]

  • 7. Effects of calcium supplements on the risk of renal stone formation in a population with low oxalate intake.
    Stitchantrakul W, Sopassathit W, Prapaipanich S, Domrongkitchaiporn S.
    Southeast Asian J Trop Med Public Health; 2004 Dec 07; 35(4):1028-33. PubMed ID: 15916110
    [Abstract] [Full Text] [Related]

  • 8. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K, Poindexter JR, Griffith CS, Pak CY.
    J Urol; 2004 Sep 07; 172(3):958-61. PubMed ID: 15311008
    [Abstract] [Full Text] [Related]

  • 9. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria.
    Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A.
    N Engl J Med; 2002 Jan 10; 346(2):77-84. PubMed ID: 11784873
    [Abstract] [Full Text] [Related]

  • 10. Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis.
    Cohanim M, Yendt ER.
    Invest Urol; 1980 Sep 10; 18(2):170-3. PubMed ID: 7410033
    [Abstract] [Full Text] [Related]

  • 11. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H, Suzuki F, Yamaguchi K, Nishikawa Y, Kotake T.
    Clin Nephrol; 1992 Jan 10; 37(1):14-8. PubMed ID: 1541059
    [Abstract] [Full Text] [Related]

  • 12. [Effect of thiazide therapy in the prophylaxis of calcium lithiasis].
    Fernández Rodríguez A, Arrabal Martín M, García Ruiz MJ, De Haro Muñoz T, Zuluaga Gómez A.
    Arch Esp Urol; 2001 Nov 10; 54(9):1047-54. PubMed ID: 11789362
    [Abstract] [Full Text] [Related]

  • 13. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE, Odvina CV, Wuermser LA, Pak CY.
    J Urol; 2007 Jun 10; 177(6):2179-84. PubMed ID: 17509313
    [Abstract] [Full Text] [Related]

  • 14. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS, Asplin JR, Frick KK, Granja I, Culbertson CD, Ng A, Grynpas MD, Bushinsky DA.
    J Am Soc Nephrol; 2015 Dec 10; 26(12):3001-8. PubMed ID: 25855777
    [Abstract] [Full Text] [Related]

  • 15. Effect of high and low calcium diets on stone forming risk during liberal oxalate intake.
    Matsumoto ED, Heller HJ, Adams-Huet B, Brinkley LJ, Pak CY, Pearle MS.
    J Urol; 2006 Jul 10; 176(1):132-6. PubMed ID: 16753387
    [Abstract] [Full Text] [Related]

  • 16. [Idiopathic hypercalciuria in childhood].
    Reusz G.
    Orv Hetil; 1998 Dec 06; 139(49):2957-62. PubMed ID: 9879200
    [Abstract] [Full Text] [Related]

  • 17. Diet and renal stone formation.
    Trinchieri A.
    Minerva Med; 2013 Feb 06; 104(1):41-54. PubMed ID: 23392537
    [Abstract] [Full Text] [Related]

  • 18. Biochemical control of bone loss and stone-forming propensity by potassium-calcium citrate after bariatric surgery.
    Sakhaee K, Griffith C, Pak CY.
    Surg Obes Relat Dis; 2012 Feb 06; 8(1):67-72. PubMed ID: 21703942
    [Abstract] [Full Text] [Related]

  • 19. Resorptive and absorptive hypercalciuria. Therapy with sodium cellulose phosphate or thiazides.
    Hering F, Lutzeyer W.
    Eur Urol; 1979 Feb 06; 5(1):29-31. PubMed ID: 428408
    [Abstract] [Full Text] [Related]

  • 20. Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest.
    Watanabe Y, Ohshima H, Mizuno K, Sekiguchi C, Fukunaga M, Kohri K, Rittweger J, Felsenberg D, Matsumoto T, Nakamura T.
    J Bone Miner Res; 2004 Nov 06; 19(11):1771-8. PubMed ID: 15476576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.